131 related articles for article (PubMed ID: 59307)
1. CCNU and bleomycin in the treatment of cancer: a Southwest Oncology Group Study.
Hoogstraten B; Haas CD; Haut A; Talley RW; Rivkin S; Isaacs BL
Med Pediatr Oncol; 1975; 1(2):95-106. PubMed ID: 59307
[TBL] [Abstract][Full Text] [Related]
2. Treatment of metastatic testicular carcinoma with bleomycin (NSC-125066) used alone or in combination with CCNU (NSC-79037).
Sonntag RW; Brunner KW; Batz K; Ryssel HJ
Cancer Chemother Rep; 1975; 59(2 Pt 1):429-31. PubMed ID: 50125
[No Abstract] [Full Text] [Related]
3. A randomized pilot study comparing two regimens in the treatment of squamous cell carcinoma.
Moseley HS; Sasaki T; McConnell DB; Merhoff GC; Wilson WL; Grage TB; Wiess AJ; Fletcher WS
J Surg Oncol; 1976; 8(1):35-42. PubMed ID: 55523
[TBL] [Abstract][Full Text] [Related]
4. Phase II trial with bleomycin, CCNU, and streptozotocin in patients with metastatic cancer of the breast.
Band PR; Canellos GP; Sears M; Israel L; Pocock SJ
Cancer Treat Rep; 1977 Oct; 61(7):1365-7. PubMed ID: 73416
[No Abstract] [Full Text] [Related]
5. Adriamycin, bleomycin, and CCNU as effective induction chemotherapeutic agents in advanced squamous cell carcinoma (COG Protocol 7333).
Scarborough JP; Metter GE; Stephens Moseley H; Kraybill WG; Davenport C; Strawitz JG; Cobau CD; Golomb FM; Fletcher WS
J Surg Oncol; 1978; 10(6):501-9. PubMed ID: 83452
[TBL] [Abstract][Full Text] [Related]
6. [Etretinate (Ro 10-9359, Tigason) and CCNU (1-(2-chloroethyl)-3-cyclohexyl-l-nitrosourea) and bleomycin versus CCNU and bleomycin in the treatment of advanced squamous cell carcinoma of the bronchus (Working group on Internal Medicine Oncology Study BS1/78)].
Weber W; Arnold H; Drings P; Germano G; Müller KM; Queisser W; Westerhausen M; Obrecht JP
Onkologie; 1983 Apr; 6(2):62-5. PubMed ID: 6191263
[TBL] [Abstract][Full Text] [Related]
7. Hexamethylmelamine, bleomycin, and CCNU chemotherapy for patients with squamous cell carcinoma, large cell carcinoma, and adenocarcinoma of the lung unresponsive to cyclophosphamide, adriamycin, methotrexate, and procarbazine.
Mintz U; Bitran JD; Cooksey JA; Desser RK; DeMeester TR; Golomb HM
Cancer Treat Rep; 1978 Apr; 62(4):567-9. PubMed ID: 77725
[No Abstract] [Full Text] [Related]
8. CCNU-adriamycin therapy in bronchogenic carcinoma.
Trowbridge RC; Kennedy BJ; Vosika GJ
Cancer; 1978 May; 41(5):1704-9. PubMed ID: 206337
[TBL] [Abstract][Full Text] [Related]
9. Combination CCNU and bleomycin therapy for squamous cell carcinoma.
Lindell TD; Moseley HS; Fletcher WS
Am Surg; 1974 May; 40(5):281-9. PubMed ID: 4132376
[No Abstract] [Full Text] [Related]
10. Bleomycin (NSC-125066) and CCNU (NSC-79037) in the combination chemotherapy of mopp-resistant hodgkin's disease.
Kurnick JE; White M; Ware DE; Robinson WA
Cancer Chemother Rep; 1975; 59(6):1147-50. PubMed ID: 56989
[TBL] [Abstract][Full Text] [Related]
11. Treatment of advanced malignancy with CCNU (NSC 79037): a phase II cooperative study with long-term follow up.
Cruz AB; Metter G; Armstrong DM; Aust JB; Fletcher WS; Wilson WL; Richardson JD
Cancer; 1976 Sep; 38(3):1069-76. PubMed ID: 953955
[TBL] [Abstract][Full Text] [Related]
12. Phase II evaluation of bleomycin. A Southwest oncology Group study.
Haas CD; Coltman CA; Gottlieb JA; Haut A; Luce JK; Talley RW; Samal B; Wilson HE; Hoogstraten B
Cancer; 1976 Jul; 38(1):8-12. PubMed ID: 59628
[TBL] [Abstract][Full Text] [Related]
13. Combination chemotherapy of advanced previously treated Hodgkin's disease with streptozotocin, CCNU, adriamycin and bleomycin.
Levi JA; Wiernik PH; Diggs CH
Med Pediatr Oncol; 1977; 3(1):33-40. PubMed ID: 65727
[TBL] [Abstract][Full Text] [Related]
14. COMB (cyclophosphamide, oncovin, methyl-CCNU, and bleomycin): a four-drug combination in solid tumors.
Livingston RB; Einhorn LH; Bodey GP; Burgess MA; Freireich EJ; Gottlieb JA
Cancer; 1975 Aug; 36(2):327-32. PubMed ID: 50870
[TBL] [Abstract][Full Text] [Related]
15. Trial of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU; NSC-79037) in advanced bronchogenic carcinoma 1,2,3.
Stolinsky DC; Bull FE; Pajak TF; Bateman JR
Oncology; 1975; 31(5-6):288-92. PubMed ID: 174040
[TBL] [Abstract][Full Text] [Related]
16. Comparison of methyl-CCNU and CCNU in patients with advanced forms of Hodgkin's disease, lymphosarcoma nad reticulum cell sarcoma.
Maurice P; Glidewell O; Jacquillat C; Silver RT; Carey R; Pas AT; Cornell CJ; Burningham RA; Nissen NI; Holland JF
Cancer; 1978 May; 41(5):1658-63. PubMed ID: 348294
[TBL] [Abstract][Full Text] [Related]
17. Combination chemotherapy with three marginally effective agents, CCNU, vincristine, and bleomycin, in the treatment of stage III melanoma.
De Wasch G; Bernheim J; Michel J; Lejeune F; Kenis Y
Cancer Treat Rep; 1976 Sep; 60(9):1273-6. PubMed ID: 65222
[TBL] [Abstract][Full Text] [Related]
18. Radiotherapy combined with procarbazine, bleomycin, and CCNU in the treatment of high-grade supratentorial astrocytomas.
Seiler RW; Greiner RH; Zimmerman A; Markwalder H
J Neurosurg; 1978 Jun; 48(6):861-5. PubMed ID: 77898
[TBL] [Abstract][Full Text] [Related]
19. The nitrosoureas: carmustine (BCNU) and lomustine (CCNU).
Weiss RB; Issell BF
Cancer Treat Rev; 1982 Dec; 9(4):313-30. PubMed ID: 6762924
[No Abstract] [Full Text] [Related]
20. A combination of adriamycin, CCNU and hydroxyurea in the treatment of disseminated bronchogenic carcinoma.
Alberto P; Barrelet L; Chapuis B; Garcia B
Eur J Cancer (1965); 1975 Nov; 11(11):795-9. PubMed ID: 767111
[No Abstract] [Full Text] [Related]
[Next] [New Search]
